Clinical trial
Dapagliflozin Effect on Rheumatic Mitral Stenosis
NCT05618223 is registered in ClinicalTrials.gov with Universitas Sebelas Maret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dapagliflozin Effect on Rheumatic Mitral Stenosis
- Lead sponsor
- Universitas Sebelas Maret
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 1, 2022
- Completion date
- June 30, 2023
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, mitral stenosis, rheumatic heart disease